West Pharmaceutical Services Inc
WST· NYSE
Released Feb 12, 2026, before the open
10-K filed Feb 17, 2026, 48 days after period end · 0000105770-26-000010
derived · Computed from the longer spans the company filed.
| Metric | Q4 2025dderived from reported figures | Q4 2024dderived from reported figures | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures |
|---|---|---|---|---|
| Revenue | $805.00M | $748.80M | $732.00M | $708.70M |
| Net Income | $132.10M |
West Pharmaceutical Services Inc · CIK 105770 · Engraved from SEC EDGAR
| $130.10M |
| $137.00M |
| $103.00M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.